Niranib 100 Mg (Niraparib) – 30 Capsules

Niranib 100 Mg (Niraparib) works by targeting and inhibiting PARP enzymes. These enzymes play a crucial role in repairing damaged DNA in cells. By inhibiting PARP, Niranib 100 mg prevents cancer cells, particularly those with BRCA mutations, from repairing their DNA effectively, leading to cell death. This targeted approach is especially beneficial for treating certain types of cancer with specific genetic alterations.

Niranib 100 mg is primarily indicated for:

• Ovarian Cancer: Niranib is used as a maintenance treatment for adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.
• Patients with BRCA Gene Mutations: Niranib has shown effectiveness in patients with ovarian cancer who have inherited (germline) or acquired (somatic) BRCA gene mutations.

Product Feature:

Essential medications for Ovarian Cancer, such as Niranib 100 Mg (Niraparib), can be procured from Unit Pharmacy!